Literature DB >> 18784313

Comparison of three commercial methods for rapid detection of Clostridium difficile toxins A and B from fecal specimens.

L Alcalá1, L Sánchez-Cambronero, M P Catalán, M Sánchez-Somolinos, M T Peláez, M Marín, E Bouza.   

Abstract

Three rapid enzyme immunoassays (X/pect Clostridium difficile Toxin A/B test, Wampole Tox A/B Quik Chek, and ImmunoCard Toxins A&B) were compared for the diagnosis of Clostridium difficile infection. Of the 367 stool specimens tested, 102 (27.8%) were positive for toxigenic C. difficile when a combination of direct cytotoxicity assay and cytotoxic culture was used as the gold standard. Sensitivity/specificity values were 49.0%/95.8%, 54.9%/95.5%, and 66.7%/95.1%, respectively. The median times to test five stool specimens were 28, 30, and 24 min, respectively. The ImmunoCard test was the quickest and most sensitive test of the three enzyme immunoassays evaluated.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18784313      PMCID: PMC2576614          DOI: 10.1128/JCM.01060-08

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  10 in total

1.  Prospective multicenter evaluation of a new immunoassay and real-time PCR for rapid diagnosis of Clostridium difficile-associated diarrhea in hospitalized patients.

Authors:  Renate J van den Berg; Lesla S Bruijnesteijn van Coppenraet; Hendrik-Jan Gerritsen; Hubert P Endtz; Eric R van der Vorm; Ed J Kuijper
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

2.  "Second-look" cytotoxicity: an evaluation of culture plus cytotoxin assay of Clostridium difficile isolates in the laboratory diagnosis of CDAD.

Authors:  E Bouza; T Peláez; R Alonso; P Catalán; P Muñoz; M R Créixems
Journal:  J Hosp Infect       Date:  2001-07       Impact factor: 3.926

3.  Evaluation of two rapid immunochromatography tests for the detection of Clostridium difficile toxins.

Authors:  Zmira Samra; Avia Luzon; Jihad Bishara
Journal:  Dig Dis Sci       Date:  2007-11-08       Impact factor: 3.199

4.  Cytotoxicity assay in antibiotic-associated colitis.

Authors:  T W Chang; M Lauermann; J G Bartlett
Journal:  J Infect Dis       Date:  1979-11       Impact factor: 5.226

5.  Detection of Clostridium difficile toxin: comparison of enzyme immunoassay results with results obtained by cytotoxicity assay.

Authors:  Daniel M Musher; Atisha Manhas; Pranav Jain; Franziska Nuila; Amna Waqar; Nancy Logan; Bernard Marino; Edward A Graviss
Journal:  J Clin Microbiol       Date:  2007-06-13       Impact factor: 5.948

Review 6.  Clostridium difficile--associated diarrhea.

Authors:  S Johnson; D N Gerding
Journal:  Clin Infect Dis       Date:  1998-05       Impact factor: 9.079

7.  [Evaluation of four immunoenzymatic tests for detecting Clostridium difficile toxins A and B].

Authors:  I Poilane; C Humeniuk-Ainouz; K Benboujida; A Kharbach; P Cruaud; A Collignon
Journal:  Pathol Biol (Paris)       Date:  2006-10-05

8.  ["Second look" at cytotoxin B of Clostridium difficile in the course of diarrhea associated with antibiotic therapy].

Authors:  P Sednaoui; B el Mantih; M Cauwell
Journal:  Pathol Biol (Paris)       Date:  1999-05

9.  [Usefulness of immunological detection of both toxin A and toxin B in stool samples for rapid diagnosis of Clostridium difficile-associated diarrhea].

Authors:  Masahiro Toyokawa; Akiko Ueda; Isao Nishi; Seishi Asari; Keiko Adachi; Megumi Annaka; Takashi Inamatsu
Journal:  Kansenshogaku Zasshi       Date:  2007-01

10.  Evaluation of two immunochromatographic tests (ImmunoCard Toxins A&B, Xpect C. difficile Toxin A&B) and PCR for the detection of Clostridium difficile toxins in faecal samples.

Authors:  Bram M W Diederen; Harold Verbakel; Anneke Bergmans; Marcel F Peeters
Journal:  J Infect       Date:  2007-04-06       Impact factor: 6.072

  10 in total
  26 in total

1.  Comparison of GenomEra C. difficile and Xpert C. difficile as confirmatory tests in a multistep algorithm for diagnosis of Clostridium difficile infection.

Authors:  Luis Alcalá; Elena Reigadas; Mercedes Marín; Antonia Fernández-Chico; Pilar Catalán; Emilio Bouza
Journal:  J Clin Microbiol       Date:  2014-11-12       Impact factor: 5.948

2.  A multiplex, internally controlled real-time PCR assay for detection of toxigenic Clostridium difficile and identification of hypervirulent strain 027/ST-1.

Authors:  A M Hoegh; J B Nielsen; A Lester; A Friis-Møller; K Schønning
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-09-22       Impact factor: 3.267

3.  Comparison of two commercial molecular assays to a laboratory-developed molecular assay for diagnosis of Clostridium difficile infection.

Authors:  Tess Karre; Lynne Sloan; Robin Patel; Jayawant Mandrekar; Jon Rosenblatt
Journal:  J Clin Microbiol       Date:  2010-12-01       Impact factor: 5.948

4.  Diagnostic algorithm using a sensitive broth culture method for detection of Clostridium difficile toxin from stool samples.

Authors:  Paul Bayardelle
Journal:  Can J Infect Dis Med Microbiol       Date:  2009       Impact factor: 2.471

5.  Clostridioides difficile laboratory diagnostic techniques: a comparative approach of rapid and molecular methods.

Authors:  Thais Simões Camargo; Moacyr Silva Junior; Luis Fernando Aranha Camargo; Veronica Pivetta Biotto; André Mario Doi; Paula Celia Mariko Koga; Carolina Nunes França; Marines Dalla Valle Martino
Journal:  Arch Microbiol       Date:  2021-01-18       Impact factor: 2.552

6.  Impact of clinical awareness and diagnostic tests on the underdiagnosis of Clostridium difficile infection.

Authors:  L Alcalá; E Reigadas; M Marín; A Martín; P Catalán; E Bouza
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-04-24       Impact factor: 3.267

Review 7.  Laboratory diagnosis of Clostridium difficile infection can molecular amplification methods move us out of uncertainty?

Authors:  Fred C Tenover; Ellen Jo Baron; Lance R Peterson; David H Persing
Journal:  J Mol Diagn       Date:  2011-08-18       Impact factor: 5.568

Review 8.  Clostridium difficile and inflammatory bowel disease: role in pathogenesis and implications in treatment.

Authors:  Orna Nitzan; Mazen Elias; Bibiana Chazan; Raul Raz; Walid Saliba
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

9.  Comparison of ImmunoCard Toxins A&B and the new semiautomated Vidas Clostridium difficile Toxin A&B tests for diagnosis of C. difficile infection.

Authors:  Luis Alcalá; Mercedes Marín; María Madrid; Esther Domínguez-García; Pilar Catalán; María Teresa Peláez; Mar Sánchez-Somolinos; Emilio Bouza
Journal:  J Clin Microbiol       Date:  2010-01-13       Impact factor: 5.948

10.  Clostridium difficile testing in the clinical laboratory by use of multiple testing algorithms.

Authors:  Susan M Novak-Weekley; Elizabeth M Marlowe; John M Miller; Joven Cumpio; Jim H Nomura; Paula H Vance; Alice Weissfeld
Journal:  J Clin Microbiol       Date:  2010-01-13       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.